Elanco Animal Health Inc (ELAN) CFO discloses purchase of 6,950 shares

Rhea-AI Filing Summary

Elanco Animal Health Inc. executive Robert M. VanHimbergen, the company’s EVP and CFO, reported buying 6,950 shares of common stock on December 11, 2025. The shares were purchased at a weighted average price of $21.6441 per share, with individual trades executed between $21.60 and $21.70 per share.

Following this transaction, he beneficially owns 124,233 shares of Elanco common stock held directly. The reported balance includes 7,426 shares that were previously reported but inadvertently omitted from his prior reported holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VanHimbergen Robert M

(Last) (First) (Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS IN 46221

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/11/2025		P		6,950	A	$21.6441(1)	124,233(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the weighted average price of 6,950 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on December 11, 2025 with purchase prices ranging from $21.60 to $21.70 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

2. The balance includes 7,426 shares that were previously reported but inadvertently omitted from the reporting person's balance on his last Form 4.

	/s/ Amy C. Seidel, Attorney-in-Fact for Robert M. VanHimbergen	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transaction did Elanco (ELAN) report in this filing?

The filing shows that EVP and CFO Robert M. VanHimbergen purchased 6,950 shares of Elanco common stock on December 11, 2025 in a reported open-market transaction code P.

At what prices did the Elanco (ELAN) CFO buy the 6,950 shares?

The 6,950 Elanco shares were bought at a weighted average price of $21.6441 per share, with individual purchase prices ranging from $21.60 to $21.70 per share.

How many Elanco (ELAN) shares does the CFO own after this transaction?

After the reported purchase, the EVP and CFO beneficially owns 124,233 shares of Elanco common stock in direct ownership.

Does the updated Elanco (ELAN) share balance include previously omitted shares?

Yes. The filing notes that the 124,233-share balance includes 7,426 shares that were previously reported but inadvertently omitted from the reporting person’s prior balance.

Who is the reporting person in this Elanco (ELAN) insider filing and what is their role?

The reporting person is Robert M. VanHimbergen, who serves as Executive Vice President (EVP) and Chief Financial Officer (CFO) of Elanco Animal Health Inc.

Is this Elanco (ELAN) insider report filed by a single reporting person?

Yes. The form indicates it is filed by one reporting person, not a joint or group filing.